These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 15208363)

  • 1. Corticotropin-releasing factor 2 receptor localization in skeletal muscle.
    Samuelsson S; Lange JS; Hinkle RT; Tarnopolsky M; Isfort RJ
    J Histochem Cytochem; 2004 Jul; 52(7):967-77. PubMed ID: 15208363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the CRF 2 receptor modulates skeletal muscle mass under physiological and pathological conditions.
    Hinkle RT; Donnelly E; Cody DB; Samuelsson S; Lange JS; Bauer MB; Tarnopolsky M; Sheldon RJ; Coste SC; Tobar E; Stenzel-Poore MP; Isfort RJ
    Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E889-98. PubMed ID: 12959937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a CRF2R agonist and exercise on mdx and wildtype skeletal muscle.
    Hall JE; Kaczor JJ; Hettinga BP; Isfort RJ; Tarnopolsky MA
    Muscle Nerve; 2007 Sep; 36(3):336-41. PubMed ID: 17503504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of CRF2R agonist on tumor growth and cachexia in mice implanted with Lewis lung carcinoma cells.
    Argilés JM; Figueras M; Ametller E; Fuster G; Olivan M; de Oliveira CC; López-Soriano FJ; Isfort RJ; Busquets S
    Muscle Nerve; 2008 Feb; 37(2):190-5. PubMed ID: 17912749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of corticotropin releasing factor 2 receptor selective sauvagine analogues for treatment of skeletal muscle atrophy.
    Isfort RJ; Wang F; Tscheiner M; Donnelly E; Bauer MB; Lefever F; Hinkle RT; Mazur AW
    J Med Chem; 2005 Jan; 48(1):262-5. PubMed ID: 15634020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sauvagine analogs selective for corticotropin releasing factor 2 receptor: effect of substitutions at positions 35 and 39 on CRF2R selectivity.
    Mazur AW; Wang F; Tscheiner M; Donnelly E; Isfort RJ
    Peptides; 2005 May; 26(5):887-91. PubMed ID: 15808919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin releasing factor 2 receptor agonists reduce the denervation-induced loss of rat skeletal muscle mass and force and increase non-atrophying skeletal muscle mass and force.
    Hinkle RT; Donnelly E; Cody DB; Bauer MB; Sheldon RJ; Isfort RJ
    J Muscle Res Cell Motil; 2004; 25(7):539-47. PubMed ID: 15711884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urocortin II treatment reduces skeletal muscle mass and function loss during atrophy and increases nonatrophying skeletal muscle mass and function.
    Hinkle RT; Donnelly E; Cody DB; Bauer MB; Isfort RJ
    Endocrinology; 2003 Nov; 144(11):4939-46. PubMed ID: 12960070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of gene expression in muscle and fat in tumor-bearing rats: effects of CRF2R agonist on cachexia.
    Argilés JM; Fontes-Oliveira CC; Fuster G; Ametller E; Figueras M; Olivan M; Lopez-Soriano FJ; Qu X; Demuth J; Stevens P; Varbanov A; Wang F; Isfort RJ; Busquets S
    Muscle Nerve; 2010 Dec; 42(6):936-49. PubMed ID: 21104868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presynaptic localization of a truncated isoform of the type 2 corticotropin releasing factor receptor in the cerebellum.
    Tian JB; Shan X; Bishop GA; King JS
    Neuroscience; 2006; 138(2):691-702. PubMed ID: 16413121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase-2 expression and promoter/enhancer activity in skeletal muscle atrophy.
    Skittone LK; Liu X; Tseng A; Kim HT
    J Orthop Res; 2008 Mar; 26(3):357-63. PubMed ID: 17960656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticotropin-releasing factor and its receptors in the brain of rats with insulin and corticosterone deficits.
    Huang Q; Timofeeva E; Richard D
    J Mol Endocrinol; 2006 Oct; 37(2):213-26. PubMed ID: 17032740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRF receptors in the rodent and human cardiovascular systems: species differences.
    Waser B; Rehmann R; Rivier J; Vale W; Reubi JC
    Peptides; 2006 Dec; 27(12):3029-38. PubMed ID: 16920225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with a corticotrophin releasing factor 2 receptor agonist modulates skeletal muscle mass and force production in aged and chronically ill animals.
    Hinkle RT; Lefever FR; Dolan ET; Reichart DL; Zwolshen JM; Oneill TP; Maloney KG; Mattson JP; Ferreira LF; Musch TI; Poole DC; Isfort RJ
    BMC Musculoskelet Disord; 2011 Jan; 12():15. PubMed ID: 21235761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localized increases in corticotropin-releasing factor receptors in pulp after dental injury.
    Rutz JC; Hatton JF; Hildebolt C; Wells JE; Rowland KC
    J Endod; 2007 Nov; 33(11):1319-24. PubMed ID: 17963955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Region specific gene expression profile in mouse brain after chronic corticotropin releasing factor receptor 1 activation: the novel role for diazepam binding inhibitor in contextual fear conditioning.
    Sherrin T; Blank T; Saravana R; Rayner M; Spiess J; Todorovic C
    Neuroscience; 2009 Aug; 162(1):14-22. PubMed ID: 19362130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of the renin-angiotensin system components to the skeletal muscle microcirculation.
    Agoudemos MM; Greene AS
    Microcirculation; 2005 Dec; 12(8):627-36. PubMed ID: 16284004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modifications of the human urocortin 2 peptide that improve pharmacological properties.
    Isfort RJ; Wang F; Tscheiner M; Dolan E; Bauer MB; Lefever F; Reichart D; Wehmeyer KR; Reilman RA; Keck BD; Hinkle RT; Mazur AW
    Peptides; 2006 Jul; 27(7):1806-13. PubMed ID: 16476507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for the presence of the type 2 corticotropin releasing factor receptor in the rodent cerebellum.
    Bishop GA; Tian JB; Stanke JJ; Fischer AJ; King JS
    J Neurosci Res; 2006 Nov; 84(6):1255-69. PubMed ID: 16955482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticotropin-releasing factor, urocortin 1, and their receptors in the mouse spinal cord.
    Korosi A; Kozicz T; Richter J; Veening JG; Olivier B; Roubos EW
    J Comp Neurol; 2007 Jun; 502(6):973-89. PubMed ID: 17444496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.